PLXNB2 and intrahepatic cholangiocarcinoma: We detected multiple genomic HBV integrations in two distinct types of liver cancer, with recurrent events at TERT, ZMAT4, MET, ANKFN1, PLXNB2 in ICC, and TERT, ALKBH5 in CHC.